Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis

Gordon D. Benson, Kentaro Kikuchi, Hiroshi Miyakawa, Atsushi Tanaka, Mitchell R. Watnik, M. Eric Gershwin

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Antimitochondrial antibodies (AMAs) are the classic serologic marker in primary biliary cirrhosis (PBC). However, there have been only limited attempts to study changes in titer or isotype analysis of such AMAs in patients followed for long periods of time. We took advantage of stored sera from well-characterized patients with PBC followed for a period of 7-28 years (mean duration of 13.5 years). Immunoblot and enzyme-linked immunosorbant assays were performed against PDC-E2, BCOADC-E2 and OGDC-E2 as well as isotype analysis of antigen-specific IgG, IgA and IgM antibodies against each of these mitochondrial autoantigens. Sera were analyzed for total IgG, IgA and IgM by radial immunodiffusion. The sera titer of AMAs was significantly higher in younger patients with PBC. Indeed, age of onset of clinical PBC was a significant predictor for the highest values of sera AMAs. In contrast, the AMA titer did not significantly change over time in this prolonged longitudinal study. The total sera levels of the individual immunoglobulins did not show a time-dependent change, when based on age of onset of the disease. Higher titers of AMAs were noted in the younger patients. Furthermore, despite this long follow-up, there was no evidence for a significant change in AMA levels; also, levels were not influenced by drug therapy used during the period of observation.

Original languageEnglish (US)
Pages (from-to)129-133
Number of pages5
JournalClinical and Developmental Immunology
Volume11
Issue number2
DOIs
StatePublished - Jun 2004

Fingerprint

Biliary Liver Cirrhosis
Antibodies
Serum
dihydrolipoamide succinyltransferase
Age of Onset
Immunoglobulin A
Immunoglobulin M
Immunoglobulin G
Immunodiffusion
Autoantigens
Longitudinal Studies
Immunoglobulins
Observation
Antigens
Drug Therapy
Enzymes

Keywords

  • Antimitochondrial antibodies
  • ELISA
  • Immunoblot assay
  • Primary biliary cirrhosis

ASJC Scopus subject areas

  • Immunology
  • Cell Biology
  • Developmental Biology

Cite this

Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. / Benson, Gordon D.; Kikuchi, Kentaro; Miyakawa, Hiroshi; Tanaka, Atsushi; Watnik, Mitchell R.; Gershwin, M. Eric.

In: Clinical and Developmental Immunology, Vol. 11, No. 2, 06.2004, p. 129-133.

Research output: Contribution to journalArticle

Benson, Gordon D. ; Kikuchi, Kentaro ; Miyakawa, Hiroshi ; Tanaka, Atsushi ; Watnik, Mitchell R. ; Gershwin, M. Eric. / Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. In: Clinical and Developmental Immunology. 2004 ; Vol. 11, No. 2. pp. 129-133.
@article{d1cd3551bbd84ae397907e34e5c1651a,
title = "Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis",
abstract = "Antimitochondrial antibodies (AMAs) are the classic serologic marker in primary biliary cirrhosis (PBC). However, there have been only limited attempts to study changes in titer or isotype analysis of such AMAs in patients followed for long periods of time. We took advantage of stored sera from well-characterized patients with PBC followed for a period of 7-28 years (mean duration of 13.5 years). Immunoblot and enzyme-linked immunosorbant assays were performed against PDC-E2, BCOADC-E2 and OGDC-E2 as well as isotype analysis of antigen-specific IgG, IgA and IgM antibodies against each of these mitochondrial autoantigens. Sera were analyzed for total IgG, IgA and IgM by radial immunodiffusion. The sera titer of AMAs was significantly higher in younger patients with PBC. Indeed, age of onset of clinical PBC was a significant predictor for the highest values of sera AMAs. In contrast, the AMA titer did not significantly change over time in this prolonged longitudinal study. The total sera levels of the individual immunoglobulins did not show a time-dependent change, when based on age of onset of the disease. Higher titers of AMAs were noted in the younger patients. Furthermore, despite this long follow-up, there was no evidence for a significant change in AMA levels; also, levels were not influenced by drug therapy used during the period of observation.",
keywords = "Antimitochondrial antibodies, ELISA, Immunoblot assay, Primary biliary cirrhosis",
author = "Benson, {Gordon D.} and Kentaro Kikuchi and Hiroshi Miyakawa and Atsushi Tanaka and Watnik, {Mitchell R.} and Gershwin, {M. Eric}",
year = "2004",
month = "6",
doi = "10.1080/10446670410001722113",
language = "English (US)",
volume = "11",
pages = "129--133",
journal = "Journal of Immunology Research",
issn = "2314-8861",
publisher = "Hindawi Publishing Corporation",
number = "2",

}

TY - JOUR

T1 - Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis

AU - Benson, Gordon D.

AU - Kikuchi, Kentaro

AU - Miyakawa, Hiroshi

AU - Tanaka, Atsushi

AU - Watnik, Mitchell R.

AU - Gershwin, M. Eric

PY - 2004/6

Y1 - 2004/6

N2 - Antimitochondrial antibodies (AMAs) are the classic serologic marker in primary biliary cirrhosis (PBC). However, there have been only limited attempts to study changes in titer or isotype analysis of such AMAs in patients followed for long periods of time. We took advantage of stored sera from well-characterized patients with PBC followed for a period of 7-28 years (mean duration of 13.5 years). Immunoblot and enzyme-linked immunosorbant assays were performed against PDC-E2, BCOADC-E2 and OGDC-E2 as well as isotype analysis of antigen-specific IgG, IgA and IgM antibodies against each of these mitochondrial autoantigens. Sera were analyzed for total IgG, IgA and IgM by radial immunodiffusion. The sera titer of AMAs was significantly higher in younger patients with PBC. Indeed, age of onset of clinical PBC was a significant predictor for the highest values of sera AMAs. In contrast, the AMA titer did not significantly change over time in this prolonged longitudinal study. The total sera levels of the individual immunoglobulins did not show a time-dependent change, when based on age of onset of the disease. Higher titers of AMAs were noted in the younger patients. Furthermore, despite this long follow-up, there was no evidence for a significant change in AMA levels; also, levels were not influenced by drug therapy used during the period of observation.

AB - Antimitochondrial antibodies (AMAs) are the classic serologic marker in primary biliary cirrhosis (PBC). However, there have been only limited attempts to study changes in titer or isotype analysis of such AMAs in patients followed for long periods of time. We took advantage of stored sera from well-characterized patients with PBC followed for a period of 7-28 years (mean duration of 13.5 years). Immunoblot and enzyme-linked immunosorbant assays were performed against PDC-E2, BCOADC-E2 and OGDC-E2 as well as isotype analysis of antigen-specific IgG, IgA and IgM antibodies against each of these mitochondrial autoantigens. Sera were analyzed for total IgG, IgA and IgM by radial immunodiffusion. The sera titer of AMAs was significantly higher in younger patients with PBC. Indeed, age of onset of clinical PBC was a significant predictor for the highest values of sera AMAs. In contrast, the AMA titer did not significantly change over time in this prolonged longitudinal study. The total sera levels of the individual immunoglobulins did not show a time-dependent change, when based on age of onset of the disease. Higher titers of AMAs were noted in the younger patients. Furthermore, despite this long follow-up, there was no evidence for a significant change in AMA levels; also, levels were not influenced by drug therapy used during the period of observation.

KW - Antimitochondrial antibodies

KW - ELISA

KW - Immunoblot assay

KW - Primary biliary cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=3242675923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242675923&partnerID=8YFLogxK

U2 - 10.1080/10446670410001722113

DO - 10.1080/10446670410001722113

M3 - Article

C2 - 15330448

AN - SCOPUS:3242675923

VL - 11

SP - 129

EP - 133

JO - Journal of Immunology Research

JF - Journal of Immunology Research

SN - 2314-8861

IS - 2

ER -